1. Introduction
===============

Secondary hyperparathyroidism (SHPT) is a manifestation of chronic kidney disease (CKD) which insidiously develops in nearly all patients undergoing chronic hemodialysis treatment, with approximately 90% displaying clinical symptoms.^\[[@R1]\]^ Although novel medical treatment options have emerged in recent years, this has only slightly reduced the rate of surgery for SHPT. As reported by the US Renal Data System, the annual rate of parathyroidectomy has remained steady since 2006 with 5.4 parathyroidectomies per 1000 SHPT patients.^\[[@R2]\]^ The distribution of normal parathyroid glands has been well documented in anatomical studies by Akerström et al and Thompson et.al.^\[[@R3],[@R4]\]^ However, the first of these focused on autopsy results from 503 cases and the second was based on primary hyperparathyroid patients. Our study, however, has additional features in terms of detailing the anatomic location of the parathyroid glands in patients with secondary hyperparathyroidism. In this context, the aim of this prospective study is to document the number and location of hyperfunctioning parathyroid glands in various positions after "intended" total parathyroidectomy (i.e., removal of at least four glands) and bilateral cervical thymectomy; also to evaluate the parathyroid metabolism after this surgical procedure.

2. Anatomical considerations
============================

Normal anatomic locations for the upper and lower parathyroid glands were considered to be as follows: the orthotopic superior parathyroid glands are those residing between the cricothyroid ligament and the anatomic demarcation of the recurrent laryngeal nerve and inferior thyroid artery (Fig. [1](#F1){ref-type="fig"}, Zone I); the orthotopic inferior parathyroid glands are those located at the posterior aspect of the thyroid between the junction of the inferior thyroid artery/thyroid gland and inferior thyroid vein/thyroid gland (Fig. [2](#F2){ref-type="fig"}, Zone V). Any parathyroid glands falling outside these anatomical regions were defined as ectopic.

![Anatomical sites of superior parathyroid glands. Delineation of sites as follows: Zone I: the area at the posterior aspect of the thyroid between the cricothyroid ligament and the anatomic demarcation of the recurrent laryngeal nerve and inferior thyroid artery, Zone II: the area below the position where the inferior thyroid artery enters the thyroid and crosses the inferior laryngeal nerve, Zone III: cranially and along the posterior aspect of the superior thyroid artery, Zone IV: intrathyroidal.](medi-98-e15926-g001){#F1}

![Anatomical sites of inferior parathyroid glands. Delineation of sites as follows: Zone V: at the posterior aspect of the thyroid and between the junctions of the inferior thyroid artery/the thyroid gland and the inferior thyroid vein/the thyroid gland, Zone VI: within 1.0--1.5 cm. caudally from the point where the inferior thyroid vein enters the thyroid gland, Zone VII: along the thyrothymic ligament, Zone VIII: between the carotis sheath and esophagus below the lower pole of the thyroid.](medi-98-e15926-g002){#F2}

Based on the anatomical localizations observed during the surgery, four different sites were defined for the upper and lower parathyroid glands (Figs. [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}).

3. Materials and methods
========================

The study included 60 consecutive hemodialysis patients with SHPT who underwent parathyroidectomy between October 2013 and December 2018. Indications for surgery were based on the 2009 KDIGO guidelines on CKD and mineral-bone disorders.^\[[@R5]\]^ All patients had previously been treated with calcimimetic agents for at least one year and were referred for initial parathyroidectomy due to medically refractory SHPT. Thus, patients who, despite maximized medical treatment, failed to maintain appropriate levels of serum calcium (8.4--10.2 mg/dL), phosphate (2.5--4.6 mg/dL) and PTH between two to nine times the normal upper limit (130--600 pg/mL), were referred for surgery.

Surgery was performed under general anesthesia and with Kocher\'s neck incision. The operative procedure was bilateral neck exploration and TPTx without autotransplantation accompanied by bilateral cervical thymectomy (BCTx). All the parathyroid glands identified in the operation were photographed for archival purposes. Thus, actual anatomical locations and association with neighboring organs were clearly documented.

The adequacy of the operation was defined, as previously described by Hiramitsu et al, by the pathological confirmation of at least 4 parathyroid glands, accompanied by an iPTH value \<60 pg/mL on postoperative day 1 (POD1).^\[[@R6]\]^ After discharge the patients were followed up at 6 month intervals, when IPTH, Ca, phosphorus, and CaxP product values were measured and recorded.

The Access Intact PTH assay (Access Immunoassay Systems Intact PTH A16972, Beckman Coulter, Inc., Fullerton, CA) was used for quantitative determination of intact parathyroid hormone levels in human serum and plasma. The reference interval of this immunoassay kit is 12--88 pg/mL.

All patients had preoperative cervical ultrasound examination and technetium-99m sestamibi (99mTc-MIBI) scintigraphy to document the enlarged parathyroid glands and ectopic and/or supernumerary parathyroids deep in the mediastinum. Imaging methods did not contribute to our decision to operate or choice of surgical approach in any way and were only used for localizing glands with adenomatous or nodular hyperplasia. Intraoperative intact iPTH monitoring was not performed with this group.

For the purpose of our study, persistent hyperparathyroidism was defined as elevated iPTH within 6 months of surgery and recurrent hyperparathyroidism denoted elevated iPTH that occurs more than 6 months after TPTx plus BCTx. All the factors that might underlie these complications, such as ectopic gland location, supernumerary glands and surgeon inexperience were investigated and recorded and necessary corrective surgical intervention was performed as long as patient consent was given.

The study protocol was approved by the Ethics Committee of the University of Health Sciences, Bozyaka Health Practice and Research Hospital. Written informed consent was obtained from all participants before surgical intervention.

4. Statistical analysis
=======================

All analyzes were performed with SPSS 15.0 (Chicago, IL) for Windows statistical package. The mean and SD of all values were calculated. A paired *t* test was used to calculate the difference between paired observations (e.g., iPTH values before and after TPTx & BCTx). For all the analyses, a *P* value of \<.05 was considered statistically significant.

5. Results
==========

The mean age of the patients was 50.1 ± 12.0 years (range: 21--73 yrs). In-hospital mortality rate was nil in this series. The mean follow-up was 15.2 ± 14.6 (range: 1--57 mos). All, but one patient, were alive at the last follow-up. One female patient deceased during hemodialysis four years after the operation. Also, recurrent laryngeal nerve damage requiring tracheostomy occurred in one patient who was further treated with arytenoid adduction followed by speech therapy. Unilateral superior laryngeal nerve damage occurred in another patient who underwent complementary parathyroidectomy. Thus, the major morbidity rate for sixty-three operations was 3.2%. The demographics and patient characteristics are shown in Table [1](#T1){ref-type="table"}.

###### 

The characteristics and biochemistry profile of SHPT patients.

![](medi-98-e15926-g003)

US examination correctly established the largest parathyroid in 27 of 38 patients (71%). The mean diameter of the dominant nodule was 13.9 ± 7.8 mm. (5.0--45.0). MIBI scan failed to demonstrate any of the parathyroids in 38 patients (68%). Thirty patients (53.5%) required simultaneous thyroidectomy due to solitary or multinodular goiter, or because of the failure to identify the fourth parathyroid gland during bilateral neck exploration. Of these, sixteen had multinodular and three had colloidal goiter, four had Hashimoto\'s thyroiditis and four had micropapillary thyroid carcinoma. Three patients with normal thyroid tissue underwent thyroidectomy because of failure to identify the fourth parathyroid during bilateral neck exploration. iPTH values and the biochemistry profile of all SHPT patients, one day after the operation, are shown in Table [1](#T1){ref-type="table"}.

During the operation, all identified glands and thyrothymic ligament were sent to the pathology department in separate pots. From these materials, pathologists reported 3 parathyroid glands in 9 cases, 4 glands in 50 cases, and 5 glands in one patient. Thus, the total number of parathyroid glands detected in the pathological examination was 232. The iPTH values on POD1 were normal in 50 patients, with an average of 11.7 ± 14.4 pg/mL (95% CI; range: 7.8--15.7). The iPTH values obtained at the last checkup of these 50 patients were 13.3 ± 18.8 pg/mL. In this group, the number of pathologically confirmed parathyroid glands was five in one patient, four in forty-eight and three in one patient. 10 patients (16.7%) had persistent HPT after the operation. In these ten cases, the number of parathyroid glands reported by the pathology was four in two cases and three in 8 cases. Of these, three patients underwent complementary parathyroidectomy. Preoperative neck MR and/or 99mTc-MIBI SPECT/CT did not detect the missing parathyroid; thus, the area to be surgically explored was determined according to the pathology report of the undetected parathyroid. Reoperation was successful in all three patients. Operative results, pathological evaluation and the clinical course of these cases are shown in Table [2](#T2){ref-type="table"}. Finally, 53 patients had normal iPTH levels at POD1 and at the last checkup. After pathological evaluation, the final number of parathyroid glands reported was 51 patients with four; and two patients with three and five glands each.

###### 

Clinical course of ten patients with persistent hyperparathyroidism.
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In conclusion, the surgical success rates after the first and second operations (TPTx plus TTLx) in our series were 83.3% and 88.3%, respectively.

6. Mapping of the parathyroids
==============================

A total of 235 parathyroid glands were detected, photographed and removed after the operations. The number of glands harvested and their distribution according to anatomical zones are shown in Table [3](#T3){ref-type="table"}.

###### 

The distribution of parathyroids by zone.

![](medi-98-e15926-g005)

More than ninety percent of the upper parathyroids were located in Zones I and II (107/117: 92%). In addition, it was observed that more than ninety percent of the upper parathyroids located in these two zones were symmetrical. On the contrary, approximately 28% (33/118) of the lower parathyroids were ectopic and located in the thyrothymic ligament or between the carotid sheath and tracheoesophageal groove, below the lower pole of the thyroid. The ectopic left inferior parathyroid was commonly identified in Zone VII and the right inferior in Zones VII and VIII. The patient with five parathyroid glands had two right inferior glands located at Zones VII and VIII.

7. Discussion
=============

Herein, we presented a series of SHPT patients who underwent total parathyroidectomy with thyrothymic ligament excision. All of the patients in this series have complete follow-up data, including the last postoperative checkup. Surgical success rates following the first and second operations were 83.3% and 88.3%, respectively. The total number of parathyroid glands excised from sixty patients was 235. Ectopic gland(s) were not identified in only seven cases.

As found in a previous pathological study,^\[[@R3],[@R4]\]^ upper parathyroids in our series almost always settled in Zones I and II (107/117: 92%); however, roughly 30% of the lower parathyroids were found in Zones VII and VIII, which were not adjacent to the thyroid gland. Interestingly, we have not recorded any superior parathyroid gland below the anatomic demarcation of the recurrent laryngeal nerve and inferior thyroid artery.

In two studies concerning complementary parathyroidectomy, the missed glands were commonly located in the thymic tongue (24%--28.4%).^\[[@R7],[@R8]\]^ This popular location was more pronounced in another study of 902 patients with SHPT. In this study, the incidence of intrathymic glands either as inferior parathyroid, supernumerary glands or parathyromatosis was 45.3%, indicating the importance of removing the thymic tongue on both sides of the neck.^\[[@R9]\]^ In another group of 570 patients who underwent TPTx with forearm autografting, the incidence of supernumerary glands was 16.5%. Of these, 51.0% were located in the thymic tongue and almost 60% of them were identified only microscopically (in parathyromatosis pattern). This clearly indicates that postoperative hyperparathyroidism may persist over a remarkable range due to parathyromatosis, even if four parathyroid glands are excised in the initial operation.^\[[@R10]\]^ However, since all of the cases in our series had undergone TTLx, there is no possibility that the intra-operatively nondetected glands were in this location. Although none of our imaging methods revealed the missing glands, we consider the mediastinum to be their possible location. In another retrospective study, the location of missed glands was investigated in 82 patients who underwent total parathyroidectomy with the resection of the thymic tongue. In support of our conjecture, 93 missed glands were identified during reoperation and were most commonly located in the mediastinum (22/93: 24%).^\[[@R11]\]^

In our study group, we preferred total parathyroidectomy (TPTX) and thyrothymic ligament excision (TTLX) due to its' significant lower rate of recurrent or persistent hyperparathyroidism when compared with other procedures. Indeed, recurrence rates after TPTX are almost always less than 5%; while recurrence rates between 5%--80% have been reported in cases of TPTX and autotransplantation.^\[[@R12],[@R13]\]^ In two recent review articles comparing TPTX and autotransplantation with TPTX, the absolute risk reduction for recurrence and recurrence or persistence of SHPT was almost 20% less in patients who underwent TPTX.^\[[@R14],[@R15]\]^

Meanwhile, with respect to surgical approach for secondary hyperparathyroidism, the possibility of removing at least four parathyroids with a hundred percent success in a single operation seems unrealistic. In a recent study, a total success in nine cases with SHPT was achieved with a novel surgical method termed "purge parathyroidectomy," a more extensive method than the classical TPTx + TTLx.^\[[@R16]\]^ However, this technique has not been tested in other studies and a similar success has yet to be repeated. When we look at the literature, the percentage of cases where four glands are resected together is reported as between 72% and 98.5% according to the series.^\[[@R10],[@R17]\]^ Furthermore, even if four parathyroids are excised, surgical and biochemical success cannot be achieved due to the supernumerary glands found in 13% to 20% of random autopsies and 20% to 30% of patient cohorts.^\[[@R4],[@R18]--[@R20]\]^ According to data from the "Parathyroid Surgeons' Society of Japan," 2016 patients with SHPT underwent parathyroidectomy between 2009 and 2013. In this group, the percentage of cases where four or more glands were removed during the first operation was 77.7%. Persistent or recurrent hyperparathyroidism developed in 12.7% of the study group.^\[[@R17]\]^ Therefore, while we have not achieved a biochemical and surgical success rate above 90% in our own study, it is evident that even in a series handled by endocrine surgeons specialized in the subject, such a rate is likely unattainable. In this study, an intact PTH value of \<60 pg/mL in POD1, accompanied by four or more pathologically confirmed parathyroid glands, constituted surgical success. This concept was first described by Schneider et.al as an indicator of successful removal of parathyroid glands.^\[[@R7]\]^

8. Limitations
==============

However, the most important factor overlooked in the methodology of this study is the omission of frozen section during the operation. Had frozen section been applied, we probably could have detected the fourth gland in most of the eight patients whose pathological evaluation revealed only three glands. The second limitation of our study is that we did not perform Sestamibi scans plus single photon emission computed tomography to detect the missing parathyroid and subsequent computed tomography scans of chest to precisely localize the anatomic position of the gland. The high efficacy of this method in the detection of retained glands (100%) has been demonstrated in a current study.^\[[@R21]\]^

So far, this study draws attention to the anatomic localization of parathyroids in SHPT cases. Unfortunately, the number of studies on this subject is very low; with the majority emphasizing parathyroid anatomy only after secondary operations to determine the location of orthotopic or ectopic missing glands in cases with recurrent or persistent SHPT.^\[[@R8]--[@R11],[@R20]\]^ In the majority of studies, ectopic thymic parathyroids are almost always inferior and the incidence is reported as between 18%--28%.^\[[@R5],[@R8]--[@R11],[@R16],[@R20]\]^ In our study, we detected 18 parathyroids (15%) in the thyrothymic ligament.

In conclusion, in our patients with SHPT, the proportion of upper parathyroid glands located in zones III and IV is 8.5% (10/117). For the upper parathyroid gland which cannot be found intraoperatively, it is a suitable approach for dissecting Zone III dissection on the same side initially and switching to ipsilateral total thyroidectomy if the parathyroid gland is not found. However, approximately 30% of lower parathyroids have an anatomic position not adjacent to the thyroid gland. Therefore, in SHPT patients, thyrothymic ligament excision should be an essential and indispensable part of surgical treatment. Moreover, in cases where there is a missing inferior parathyroid during TPTx and TTLx, bilateral Zone VIII explorations should be performed. Additionally, the use of frozen section to verify parathyroid glands removed during surgery should be an essential part of the treatment and mandatory.

Acknowledgments
===============

Native-speaker English editing has been carried out by Claire Olmez MEd, MSc, ELT. We thank Claire for her valuable contribution.

Author contributions
====================

**Conceptualization:** Gokalp Okut.

**Data curation:** Gokalp Okut, Ismail Can Tercan, Zehra Erkul, Ahmet Aykas, Murat Karatas, Cenk Simsek.

**Formal analysis:** Ahmet Aykas, Cenk Simsek, Erhan Tatar.

**Investigation:** Adam Uslu, Gokalp Okut, Ismail Can Tercan, Ahmet Aykas, Murat Karatas, Cenk Simsek.

**Methodology:** Adam Uslu, Gokalp Okut, Ahmet Aykas, Murat Karatas, Cenk Simsek.

**Project administration:** Gokalp Okut.

**Writing -- original draft:** Adam Uslu, Erhan Tatar.

**Writing -- review & editing:** Adam Uslu, Erhan Tatar.

Abbreviations: BCTx = bilateral cervical thymectomy, CKD = chronic kidney disease, iPTH = intact parathormone, POD1 = postoperative day 1, SHPT = secondary hyperparathyroidism, TPTx = total parathyroidectomy, TTLX = thyrothymic ligament excision.

The author(s) received no financial support for the research, authorship, and/or publication of this article.

The protocol for this study was approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken, and the study conformed to the provisions of the Declaration of Helsinki.

The author(s) declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Informed consent was obtained from all participants included in the study.
